AN UNBIASED VIEW OF NAVITOCLAX

Researchers believe combining navitoclax with ruxolitinib can help people with myelofibrosis. During this trial 50 % the people have navitoclax and ruxolitinib. Another fifty percent have ruxolitinib in addition to a dummy drug (placebo ).No use of any AbbVie trademark, trade title, or trade costume in This page could possibly be made without the p